Sleep Maintenance Insomnia: Strengths and Weaknesses of Current Pharmacologic Therapies

References

• Roth T: The relationship between psychiatric diseases and insomnia. Int J Clin Pract 2001; (Suppl):3–8
   Google Scholar
• Roth T: New developments for treating sleep disorders. J Clin Psychiatry 2001; 62(Suppl 10):3–4
   PubMed Web of Science ®Google Scholar
• McCall WV: A psychiatric perspective on insomnia. J Clin Psychiatry 2001; 62(Suppl 10):27–32
   PubMed Web of Science ®Google Scholar
• Mellinger GD, Balter MB, Uhlenhuth EH: Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 1985; 42:225–232
   PubMed Web of Science ®Google Scholar
• Ancoli-Israel S, Roth T: Characteristics of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. I. Sleep 1999; 22(Suppl 2):S347–S353
   Google Scholar
• Shochat T, Umphress J, Israel AG, Ancoli-Israel S: Insomnia in primary care patients. Sleep 1999; 22(Suppl 2):S359–S365
   Google Scholar
• Ohayon MM, Zulley J: Correlates of global sleep dissatisfaction in the German population. Sleep 2001; 24:780–787
   PubMed Web of Science ®Google Scholar
• National Sleep Foundation: 2002 Sleep in America Poll. 2002:1–43
   Google Scholar
• Ancoli-Israel S: Insomnia in the elderly: A review for the primary care practitioner. Sleep 2000; 23(Suppl 1):S23–S30
   PubMed Web of Science ®Google Scholar
• Mendelson WB, Roth T, Cassella J, Roehrs T, Walsh JK, Woods JH, Buysse DJ, Meyer RE: The treatment of chronic insomnia: Drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit (NCDEU) meeting symposium. Sleep Med Rev 2004; 8:7–17
   Google Scholar
• Morin CM: Measuring outcomes in randomized clinical trials of insomnia treatments. Sleep Med Rev 2003; 7:263–279
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders-Text Revision. 4th ed Washington, DC: American Psychiatric Publishing, Inc; 2000
   Google Scholar
• Rajput V, Bromley SM: Chronic insomnia: A practical review. Am Fam Physician 1999; 60:1431–1438
   PubMed Web of Science ®Google Scholar
• Benca RM: Consequences of insomnia and its therapies. J Clin Psychiatry 2001; 62(Suppl 10):33–38
   PubMed Web of Science ®Google Scholar
• Hohagen F, Kappler C, Schramm E, Riemann D, Weyerer S, Berger M: Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening—temporal stability of subtypes in a longitudinal study on general practice attenders. Sleep 1994; 17:551–554
   PubMed Web of Science ®Google Scholar
• Littner M, Hirshkowitz M, Kramer M, Kapen S, Anderson WM, Bailey D, Berry RB, Davila D, Johnson S, Kushida C, Loube DI, Wise M, Woodson BT: Practice parameters for using polysomnography to evaluate insomnia: An update. Sleep 2003; 26:754–760
   PubMed Web of Science ®Google Scholar
• Foley DJ, Monjan AA, Brown SL, Simonsick EM, Wallace RB, Blazer DG: Sleep complaints among elderly persons: An epidemiologic study of three communities. Sleep 1995; 18:425–432
   PubMed Web of Science ®Google Scholar
• McCall WV: Management of primary sleep disorders among elderly persons. Psychiatr Serv 1995; 46:49–55
   PubMed Web of Science ®Google Scholar
• Webb WB: Sleep in older persons: Sleep structures of 50- to 60- year-old men and women. J Gerontol 1982; 37:581–586
   PubMedGoogle Scholar
• Reynolds CF III: Sleep disorders. In: Sadavoy J, Lazarus LW, Jarvik LF, GT, Grossberg eds. Comprehensive Review of Geriatric Psychiatry-II. Washington, DC: American Psychiatric Press, Inc., 1996:693–712
   Google Scholar
• Reite M, Ruddy J, Nagel K: Insomnia complaints. In: Concise Guide to Evaluation and Management of Sleep Disorders. Washington, DC: American Psychiatric Press Inc., 1997:47–112
   Google Scholar
• Szuba MP, Fernando AT, Groh-Szuba G: Sleep abnormalities in treatment-resistant mood disorders. In: Amsterdam JD, Nierenberg AA eds. Treatment Resistant Mood Disorders. Cambridge, UK: Cambridge University Press, 2001:96–110
   Google Scholar
• Gislason T, Almqvist M: Somatic diseases and sleep complaints. An epidemiological study of 3,201 Swedish men. Acta Med Scand 1987; 221:475–481
   PubMedGoogle Scholar
• McCrae CS, Lichstein KL: Managing insomnia in long-term care. Annals of Long-term Care 2002; 10:38–43
   Google Scholar
• Dorrepaal KL, Aaronson NK, van Dam FS: Pain experience and pain management among hospitalized cancer patients. A clinical study. Cancer 1989; 63:593–598
   Google Scholar
• Strang P: Emotional and social aspects of cancer pain. Acta Oncol 1992; 31:323–326
   PubMed Web of Science ®Google Scholar
• Boyle GJ, Murrihy R: A preliminary study of hormone replacement therapy and psychological mood states in perimenopausal women. Psychol Rep 2001; 88:160–170
   PubMed Web of Science ®Google Scholar
• Mitchell ES, Woods NF: Symptom experiences of midlife women: Observations from the Seattle Midlife Women’s Health Study. Maturitas 1996; 25:1–10
   PubMed Web of Science ®Google Scholar
• Moe KE: Reproductive hormones, aging, and sleep.. Semin Reprod Endocrinol 1999; 17:339–348
   PubMedGoogle Scholar
• Richardson GS, Roth T: Future directions in the management of insomnia. J Clin Psychiatry 2001; 62(Suppl 10):39–45
   PubMedGoogle Scholar
• Mitler MM, Seidel WF, van den Hoed J, Greenblatt DJ, Dement WC: Comparative hypnotic effects of flurazepam, triazolam, and placebo: A long-term simultaneous nighttime and daytime study. J Clin Psychopharmacol 1984; 4:2–13
   PubMed Web of Science ®Google Scholar
• Roehrs T, Vogel G, Vogel F, Wittig R, Zorick F, Paxton C, Lamphere J, Roth T: Dose effects of temazepam tablets on sleep. Drugs Exp Clin Res 1986; 12:693–699
   PubMedGoogle Scholar
• Ashton H: Guidelines for the rational use of benzodiazepines: when and what to use. Drugs 1994; 48:25–40
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ: Pharmacology of benzodiazepine hypnotics. J Clin Psychiatry 1992; 53(Suppl:7–13)
   Google Scholar
• Ware JC, Walsh JK, Scharf MB, Roehrs T, Roth T, Vogel GW: Minimal rebound insomnia after treatment with 10-mg zolpidem. Clin Neuropharmacol 1997; 20:116–125
   PubMed Web of Science ®Google Scholar
• Walsh JK, Erman M, Erwin CW, Jamieson A, Mahowald M, Regestein Q, Scharf M, Tigel P, Vogel G, Ware JC: Subjective hypnotic efficacy of trazodone and zolpidem in DSM-III-R primary insomnia. Hum Psychopharmacol 1998; 13:191–198
   Web of Science ®Google Scholar
• Elie R, Ruther E, Farr I, Emilien G, Salinas E: Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group. J Clin Psychiatry 1999; 60:536–544
   PubMed Web of Science ®Google Scholar
• Fry J, Scharf M, Mangano R, Fujimori M: Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group. Int Clin Psychopharmacol 2000; 15:141–152
   PubMed Web of Science ®Google Scholar
• Mitler MM: Nonselective and selective benzodiazepine receptor agonists—where are we today? Sleep 2000; 23(Suppl 1):S39–S47
   Google Scholar
• Wheatley D: Prescribing short-acting hypnosedatives. Current recommendations from a safety perspective. Drug Saf 1992; 7:106–115
   Google Scholar
• Roth T, Roehrs TA: Issues in the use of benzodiazepine therapy. J Clin Psychiatry 1992; 53(Suppl:14–18)
   Google Scholar
• IMS Health: National Prescription Audit™Plus. 2003
   Google Scholar
• AMBIEN® (zolpidem tartrate): In: Physicians’ Desk Reference. Montvale, NJ: Thomson PDR, 2003:2979–2983
   Google Scholar
• Kales A: Benzodiazepine hypnotics and insomnia. Hosp Pract (Off Ed) 1990; 25(Suppl 3):7–21
   Google Scholar
• Arana GW, Rosenbaum JF: Benzodiazepines and other anxiolytic drugs. In: Handbook of Psychiatric Drug Therapy. Philadelphia, Pa: Lippincott Williams & Wilkins, 2000:170–209
   Google Scholar
• Scharf MB, Roth T, Vogel GW, Walsh JK: A multicenter, placebo- controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry 1994; 55:192–199
   PubMed Web of Science ®Google Scholar
• Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, Schweitzer PK, Ware JC: Eight weeks of non-nightly use of zolpidem for primary insomnia. Sleep 2000; 23:1087–1096
   PubMed Web of Science ®Google Scholar
• Tsutsui S: A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia. J Int Med Res 2001; 29:163–177
   PubMedGoogle Scholar
• Krystal AD, Perlis ML, McCall WV, Zammitt G, Hirshkowitz M: Three-month non-nightly use of zolpidem for the treatment of primary insomnia. Sleep 2002; 25:A68
   Google Scholar
• Cluydts R, Peeters K, de Bouyalsky I, Lavoisy J: Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: A double-blind, randomized pilot study. J Int Med Res 1998; 26:13–24
   PubMedGoogle Scholar
• Hajak G, Cluydts R, Declerck A, Estivill SE, Middleton A, Sonka K, Unden M: Continuous versus non-nightly use of zolpidem in chronic insomnia: Results of a large-scale, double-blind, randomized, outpatient study. Int Clin Psychopharmacol 2002; 17:9–17
   PubMed Web of Science ®Google Scholar
• Weitzel KW, Wickman JM, Augustin SG, Strom JG: Zaleplon: A pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia. Clin Ther 2000; 22:1254–1267
   PubMed Web of Science ®Google Scholar
• Troy SM, Lucki I, Unruh MA, Cevallos WH, Leister CA, Martin PT, Furlan PM, Mangano R: Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance. J Clin Psychopharmacol 2000; 20:328–337
   PubMed Web of Science ®Google Scholar
• Danjou P, Paty I, Fruncillo R, Worthington P, Unruh M, Cevallos W, Martin P: A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening. Br J Clin Pharmacol 1999; 48:367–374
   PubMed Web of Science ®Google Scholar
• Drake CL, Roehrs TA, Mangano RM, Roth T: Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia. Hum Psychopharmacol 2000; 15: 595–604
   Google Scholar
• Hedner J, Yaeche R, Emilien G, Farr I, Salinas E: Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group. Int J Geriatr Psychiatry 2000; 15:704–712
   PubMed Web of Science ®Google Scholar
• Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, Gruber G, Mandl M, Strobl R, Gollner D, Prause W, Saletu B: Insomnia in depression: Differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26:249–260
   PubMed Web of Science ®Google Scholar
• Montgomery I, Oswald I, Morgan K, Adam K: Trazodone enhances sleep in subjective quality but not in objective duration. Br J Clin Pharmacol 1983; 16:139–144
   PubMed Web of Science ®Google Scholar
• Parrino L, Spaggiari MC, Boselli M, Di Giovanni G, Terzano MG: Clinical and polysomnographic effects of trazodone CR in chronic insomnia associated with dysthymia. Psychopharmacology (Berl) 1994; 116:389–395
   PubMed Web of Science ®Google Scholar
• van Bemmel AL, Havermans RG, van Diest R: Effects of trazodone on EEG sleep and clinical state in major depression. Psychopharmacology (Berl) 1992; 107:569–574
   PubMedGoogle Scholar
• Scharf MB, Sachais BA: Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients. J Clin Psychiatry 1990; 51(Suppl:13–17)
   Google Scholar
• Haffmans PM, Vos MS: The effects of trazodone on sleep disturbances induced by brofaromine. Eur Psychiatry 1999; 14:167–171
   PubMed Web of Science ®Google Scholar
• Mouret J, Lemoine P, Minuit MP, Benkelfat C, Renardet M: Effects of trazodone on the sleep of depressed subjects—a polygraphic study. Psychopharmacology (Berl) 1988; 95(Suppl:S37–S43)
   Google Scholar
• Walsh JK, Erman M, Erwin CW, et al.: Subjective hypnotic efficacy of trazodone and zolpidem in DSM-III-R primary insomnia. Hum Psychopharmacol 1998; 13:191–8
   Google Scholar
• Wallace MB: A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psych 2004; 66(4):469–476
   Google Scholar
• Ware JC, Pittard JT: Increased deep sleep after trazodone use: A double-blind placebo-controlled study in healthy young adults. J Clin Psychiatry 1990; 51(Suppl:18–22)
   Google Scholar
• Levenson JL: Prolonged QT interval after trazodone overdose. Am J Psychiatry 1999; 156:969–970
   PubMed Web of Science ®Google Scholar
• Tarantino P, Appleton N, Lansdell K: Effect of trazodone on hERG channel current and QT-interval. Eur J Pharmacol 2005; 510:75–85
   PubMed Web of Science ®Google Scholar
• Zitron E, Kiesecker C, Scholz E: Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone. Arch Pharmacol 370:146–156
   Google Scholar
• Aden GC, Thatcher C: Quazepam in the short-term treatment of insomnia in outpatients. J Clin Psychiatry 1983; 44:454–456
   Google Scholar
• Scharf MB, Roth PB, Dominguez RA, Ware JC: Estazolam and flurazepam: A multicenter, placebo-controlled comparative study in outpatients with insomnia. J Clin Pharmacol 1990; 30:461–467
   PubMed Web of Science ®Google Scholar
• Cohn JB, Wilcox CS, Bremner J, Ettinger M: Hypnotic efficacy of estazolam compared with flurazepam in outpatients with insomnia. J Clin Pharmacol 1991; 31:747–750
   Google Scholar
• Walsh JK, Targum SD, Pegram V, Allen RP, Fillingim JM, Parwatikar S: A multi-center clinical investigation of estazolam: Short-term efficacy. Current Ther Res 1984; 36:866–874
   Google Scholar
• Roth T, Tietz EI, Kramer M, Kaffeman M: The effect of a single dose of quazepam (Sch-16134) on the sleep of chronic insomniacs. J Int Med Res 1979; 7:583–587
   Google Scholar
• O’Hair DE, Winsauer HJ: Evaluation of short-term treatment with 30 mg of quazepam in insomniac outpatients. Clin Ther 1981; 4:291–301
   Google Scholar
• Tietz EI, Roth T, Zorick FJ, Piccione P, Kramer M: The acute effect of quazepam on the sleep of chronic insomniacs. A doseresponse study. Arzneimittelforschung 1981; 31:1963–1966
   Google Scholar
• Hernandez LR, Del Rosal PL, Ponce MC: Short-term study of quazepam 15 milligrams in the treatment of insomnia. J Int Med Res 1983; 11:162–166
   Google Scholar
• Mauri MC, Gianetti S, Pugnetti L, Altamura AC: Quazepam versus triazolam in patients with sleep disorders: A double-blind study. Int J Clin Pharmacol Res 1993; 13:173–177
   Google Scholar
• Sunshine A: Comparison of the hypnotic activity of triazolam, flurazepam hydrochloride, and placebo. Clin Pharmacol Ther 1975; 17:573–577
   Google Scholar
• Fabre LF Jr., McLendon DM, Harris RT: Preference studies of triazolam with standard hypnotics in out-patients with insomnia. J Int Med Res 1976; 4:247–254
   Google Scholar
• Lomen P, Linet OI: Hypnotic efficacy of triazolam and methyprylon in insomniac in-patients. J Int Med Res 1976; 4:55–58
   Google Scholar
• Vogel GW, Barker K, Gibbons P, Thurmond A: A comparison of the effects of flurazepam 30 mg and triazolam 0.5 mg on the sleep of insomniacs. Psychopharmacology (Berl) 1976; 47:81–86
   PubMed Web of Science ®Google Scholar
• Bowen AJ: Comparative efficacy of triazolam, flurazepam and placebo in out-patients insomniacs. J Int Med Res 1978; 6:337–342
   Google Scholar
• Okawa KK, Allens GS: A clinical comparison of triazolam with placebo and with secobarbital in insomniac patients. J Int Med Res 1978; 6:343–347
   Google Scholar
• Hegelbach-Feller DA, Tschopp JM, Christeller S, Fabre J: Comparison of the short-acting benzodiazepines midazolam and triazolam with placebo. Arzneimittelforschung 1988; 38:387–392
   PubMedGoogle Scholar
• Melo de Paula AJ: Comparative study of lormetazepam and flurazepam in the treatment of insomnia. Clin Ther 1984; 6:500–508
   Google Scholar
• Kripke DF, Hauri P, Ancoli-Israel S, Roth T: Sleep evaluation in chronic insomniacs during 14-day use of flurazepam and midazolam. J Clin Psychopharmacol 1990; 10:32S–43S
   Google Scholar
• Sateia MJ, Hauri P, Kripke D, Roehrs T: Clinical safety of flurazepam and midazolam during 14-day use in chronic insomniacs. J Clin Psychopharmacol 1990; 10:28S–31S
   Google Scholar
• Judd LL, Ellinwood E, McAdams LA: Cognitive performance and mood in patients with chronic insomnia during 14-day use of flurazepam and midazolam. J Clin Psychopharmacol 1990; 10:56S–67S
   Google Scholar
• Moskowitz H, Linnoila M, Roehrs T: Psychomotor performance in chronic insomniacs during 14-day use of flurazepam and midazolam. J Clin Psychopharmacol 1990; 10:44S–55S
   Google Scholar
• Linnoila M, Viukari M, Lamminsivu U, Auvinen J: Efficacy and side effects of lorazepam, oxazepam, and temazepam as sleeping aids in psychogeriatric inpatients. Int Pharmacopsychiat 1980; 15:129–135
   PubMedGoogle Scholar
• Saletu B, Saletu-Zyhlarz G, Anderer P, Brandstatter N, Frey R, Gruber G, Klosch G, Mandl M, Grunberger J, Linzmayer L: Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods. Neuropsychobiology 1997; 36(3):130–52
   Google Scholar
• Holbrook AM, Crowther R, Lotter A, Cheng C, King D: Metaanalysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000; 162:225–233
   PubMed Web of Science ®Google Scholar
• Holbrook AM, Crowther R, Lotter A, Cheng C, King D: The diagnosis and management of insomnia in clinical practice: A practical evidence-based approach. CMAJ 2000; 162:216–220
   PubMed Web of Science ®Google Scholar
• Juhl RP, Daugherty VM, Kroboth PD: Incidence of next-day anterograde amnesia caused by flurazepam hydrochloride and triazolam. Clin Pharm 1984; 3:622–625
   Google Scholar
• Johnson LC, Chernik DA, Hauri P: A multicenter 14-day study of flurazepam and midazolam in chronic insomniacs: General discussion and conclusions. J Clin Psychopharmacol 1990; 10:76S–90S
   Google Scholar
• Rickels K, Schweizer E, Case WG, Greenblatt DJ: Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Arch Gen Psychiatry 1990; 47:899–907
   PubMed Web of Science ®Google Scholar
• Dement WC: Objective measurements of daytime sleepiness and performance comparing quazepam with flurazepam in two adult populations using the Multiple Sleep Latency Test. J Clin Psychiatry 1991; 52(Suppl:31–37)
   Google Scholar
• MacPhail I, Ogilvie WA, Purvis CR: Comparison of diazepam and flurazepam in the treatment of insomnia in general practice. J Int Med Res 1979; 7:401–403
   Google Scholar
• Hartmann E, Lindsley JG, Spinweber C: Chronic insomnia: Effects of tryptophan, flurazepam, secobarbital, and placebo. Psychopharmacology (Berl) 1983; 80:138–142
   PubMed Web of Science ®Google Scholar
• Ponciano E, Freitas F, Camara J, Faria M, Barreto M, Hindmarch I: A comparison of the efficacy, tolerance and residual effects of zopiclone, flurazepam and placebo in insomniac outpatients. Int Clin Psychopharmacol 1990; 5(Suppl 2):69–77
   PubMed Web of Science ®Google Scholar
• Salkind MR, Silverstone T: A clinical and psychometric evaluation of flurazepam. Br J Clin Pharmacol 1975; 2:223–226
   PubMed Web of Science ®Google Scholar
• Elie R, Lavoie G, Bourgouin J, Le Morvan P: Zopiclone versus flurazepam in insomnia: Prolonged administration and withdrawal. Int Clin Psychopharmacol 1990; 5:279–286
   Google Scholar
• Mendels J, Stern S: Evaluation of the short-term treatment of insomnia in out-patients with 15 milligrams of quazepam. J Int Med Res 1983; 11:155–161
   Google Scholar
• Wheatley D: Zopiclone: a non-benzodiazepine hypnotic. Controlled comparison to temazepam in insomnia. Br J Psychiatry 1985; 146:312–314
   Google Scholar
• Heffron WA, Roth P: Double-blind evaluation of the safety and hypnotic efficacy of temazepam in insomniac outpatients. Br J Clin Pharmacol 1979; 8:69S–72S
   Google Scholar
• Fillingim JM: Double-blind evaluation of the efficacy and safety of temazepam in outpatients with insomnia. Br J Clin Pharmacol 1979; 8:73S–77S
   Google Scholar
• Allen RP, Mendels J, Nevins DB, Chernik DA, Hoddes E: Efficacy without tolerance or rebound insomnia for midazolam and temazepam after use for one to three months. J Clin Pharmacol 1987; 27:768–775
   PubMed Web of Science ®Google Scholar
• de Jonghe F, Ameling EH, Jonkers F, Folkers C, Schwarz RV: Flurazepam and temazepam in the treatment of insomnia in a general hospital population. Pharmacopsychiatry 1984; 17:133–135
   Google Scholar
• Mitler MM, Carskadon MA, Phillips RL, Sterling WR, Zarcone VP Jr., Spiegel R, Guilleminault C, Dement WC: Hypnotic efficacy of temazepam: a long-term sleep laboratory evaluation. Br J Clin Pharmacol 1979; 8:63S–68S
   Google Scholar
• Gringras M, Beaumont G, Ankier SI: A comparison of the hypnotic activity of loprazolam, temazepam and placebo in general practice. J Int Med Res 1984; 12:10–16
   Google Scholar
• Kales A, Manfredi RL, Vgontzas AN, Bixler EO, Vela-Bueno A, Fee EC: Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines. Clin Pharmacol Ther 1991; 49:468–476
   PubMed Web of Science ®Google Scholar
• Van Steenis D: A comparison of chlormezanone and temazepam in sleep disturbance. Curr Med Res Opin 1982; 8:28–32
   Google Scholar
• Trapani G, Lopedota A, Boghetich G, Latrofa A, Franco M, Sanna E, Liso G: Encapsulation and release of the hypnotic agent zolpidem from biodegradable polymer microparticles containing hydroxypropyl-beta-cyclodextrin. Int J Pharm 2003; 268:47–57
   PubMed Web of Science ®Google Scholar
• Uchikawa O, Fukatsu K, Tokunoh R, Kawada M, Matsumoto K, Imai Y, Hinuma S, Kato K, Nishikawa H, Hirai K, Miyamoto M, Ohkawa S: Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists. J Med Chem 2002; 45:4222–4239
   PubMed Web of Science ®Google Scholar
• Stubbs CM, Karim A: Safety, pharmacokinetics, and pharmacodynamics of TAK-375 in healthy adults. Presented at the 157th Annual Meeting of American Psychiatric Association, New York, NY, May1–62004
   Google Scholar
• Walsh JK, Lankford DD, Krystal A, Roth T, Jochelson P, Garber M, Alexander T, Burke J: Efficacy and tolerability of four doses of indiplon (NBI-34060) modified-release in elderly patients with sleep maintenance insomnia. Sleep 2003; 26:A78
   Web of Science ®Google Scholar
• Scharf MB, Rosenberg R, Cohn M, Zammit G, Rogowski R, Jochelson P, Farber R, Burke J, Campbell B: Safety and efficacy of immediate release indiplon (NBI-34060) in elderly patients with insomnia. Sleep 2003; 26:A85
   Web of Science ®Google Scholar
• Walsh JK, Roth T, Lankford A, Rosenbere R, Jochelson P: Efficacy and safety of 35-days of treatment with indiplon immediate release in adults with chronic insomnia. Presented at the 157th Annual Meeting of American Psychiatric Association, New York, NY, May1–6, 2004
   Google Scholar
• Scharf M, Seiden D, Erman M, Rosenberg R, McCall WV, Amato DA, Wessel TC. A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia (in press)
   Google Scholar
• Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T: Sustained efficacy of eszopiclone over six months of nightly treatment: Results of a randomized, double-blind, placebo controlled study in adults with chronic insomnia. Sleep 2003; 26:793–799
   PubMed Web of Science ®Google Scholar
• Zammit GK, McNabb LJ, Caron J, Amato DA, Roth T. A 6-week study of eszopiclone in chronic insomnia. Curr Med Res and Opin 2004; 20(12):1979–1991
   Google Scholar
• Rosenberg R, Caron J, Roth T, Amato D.: An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults. Sleep Medicine 2005; 6:15–22
   Google Scholar
• Shochat T, Ancoli-Israel S: Sleep and sleep disorders. In: Geriatric Medicine: Evidence Based Approach. New York, NY: Springer-Verlag, 2003, 1031–1042
   Google Scholar
• United States Census Bureau: Census 2000 Brief: The 65 years and over population: 2000. Available at: http://www.census.gov/prod/2001pubs/c2kbr01-10.pdf. Accessed September 10, 2002
   Google Scholar
• Maxmen JS: Antidepressants. In: Psychotropic Drugs: Fast Facts. W.W. Norton & Company: New York, 1991:57–97
   Google Scholar
• Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF III, Kupfer DJ: Benzodiazepines and zolpidem for chronic insomnia: A meta-analysis of treatment efficacy. JAMA 1997; 278:2170–2177
   PubMed Web of Science ®Google Scholar
• Schweizer E, Rickels K, Case WG, Greenblatt DJ: Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper. Arch Gen Psychiatry 1990; 47:908–915
   PubMed Web of Science ®Google Scholar
• Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, et al.: Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002; 159:5–11
   Google Scholar
• Morin CM, Culbert JP, Schwartz SM: Nonphmarmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994; 151:1172–80
   PubMed Web of Science ®Google Scholar